$273 Million is the total value of PURA VIDA INVESTMENTS, LLC's 70 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Exit | NEOVASC INC | $0 | – | -588,594 | -100.0% | -0.09% | – | |
| TTOO | Exit | T2 BIOSYSTEMS INC | $0 | – | -60,929 | -100.0% | -0.13% | – |
| ARAY | Exit | ACCURAY INCcall | $0 | – | -100,000 | -100.0% | -0.19% | – |
| AVGR | Exit | AVINGER INCcall | $0 | – | -150,000 | -100.0% | -0.22% | – |
| ADMP | Exit | ADAMIS PHARMACEUTICALS CORP | $0 | – | -255,000 | -100.0% | -0.27% | – |
| HZNP | Exit | HORIZON PHARMA PLCcall | $0 | – | -50,000 | -100.0% | -0.28% | – |
| ITEK | Exit | INOTEK PHARMACEUTICALS CORP | $0 | – | -111,468 | -100.0% | -0.32% | – |
| RDUS | Exit | RADIUS HEALTH INC | $0 | – | -19,775 | -100.0% | -0.32% | – |
| FLKS | Exit | FLEX PHARMA INC | $0 | – | -142,000 | -100.0% | -0.51% | – |
| OPHT | Exit | OPHTHOTECH CORPcall | $0 | – | -37,200 | -100.0% | -0.52% | – |
| EXAS | Exit | EXACT SCIENCES CORPcall | $0 | – | -100,000 | -100.0% | -0.56% | – |
| OPHT | Exit | OPHTHOTECH CORP | $0 | – | -42,500 | -100.0% | -0.60% | – |
| KITE | Exit | KITE PHARMA INCput | $0 | – | -39,500 | -100.0% | -0.67% | – |
| SGYPQ | Exit | SYNERGY PHARMACEUTICALS DEL | $0 | – | -412,500 | -100.0% | -0.69% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -105,000 | -100.0% | -0.72% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -40,000 | -100.0% | -0.75% | – |
| SPNC | Exit | SPECTRANETICS CORP | $0 | – | -100,000 | -100.0% | -0.76% | – |
| AVGR | Exit | AVINGER INC | $0 | – | -571,298 | -100.0% | -0.83% | – |
| HZNP | Exit | HORIZON PHARMA PLC | $0 | – | -151,250 | -100.0% | -0.83% | – |
| KITE | Exit | KITE PHARMA INC | $0 | – | -49,500 | -100.0% | -0.84% | – |
| RARE | Exit | ULTRAGENYX PHARMACEUTICAL IN | $0 | – | -39,750 | -100.0% | -0.86% | – |
| OFIX | Exit | ORTHOFIX INTL N V | $0 | – | -70,000 | -100.0% | -0.91% | – |
| PODD | Exit | INSULET CORP | $0 | – | -74,600 | -100.0% | -0.93% | – |
| HRC | Exit | HILL ROM HLDGS INC | $0 | – | -50,000 | -100.0% | -0.94% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -49,125 | -100.0% | -1.00% | – |
| THC | Exit | TENET HEALTHCARE CORPcall | $0 | – | -150,000 | -100.0% | -1.03% | – |
| ZLTQ | Exit | ZELTIQ AESTHETICS INC | $0 | – | -90,000 | -100.0% | -1.07% | – |
| AKRXQ | Exit | AKORN INC | $0 | – | -135,125 | -100.0% | -1.12% | – |
| ABT | Exit | ABBOTT LABScall | $0 | – | -87,700 | -100.0% | -1.13% | – |
| ALR | Exit | ALERE INC | $0 | – | -90,000 | -100.0% | -1.18% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -123,066 | -100.0% | -1.19% | – |
| MOH | Exit | MOLINA HEALTHCARE INC | $0 | – | -70,000 | -100.0% | -1.24% | – |
| JAZZ | Exit | JAZZ PHARMACEUTICALS PLC | $0 | – | -33,936 | -100.0% | -1.25% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -61,625 | -100.0% | -1.27% | – |
| XENT | Exit | INTERSECT ENT INC | $0 | – | -275,000 | -100.0% | -1.32% | – |
| THC | Exit | TENET HEALTHCARE CORPput | $0 | – | -200,000 | -100.0% | -1.38% | – |
| ZBH | Exit | ZIMMER BIOMET HLDGS INC | $0 | – | -40,652 | -100.0% | -1.60% | – |
| GSK | Exit | GLAXOSMITHKLINE PLCsponsored adr | $0 | – | -150,357 | -100.0% | -1.97% | – |
| LLY | Exit | LILLY ELI & COcall | $0 | – | -81,500 | -100.0% | -1.99% | – |
| EVHC | Exit | ENVISION HEALTHCARE HLDGS INput | $0 | – | -300,000 | -100.0% | -2.03% | – |
| EVHC | Exit | ENVISION HEALTHCARE HLDGS IN | $0 | – | -307,046 | -100.0% | -2.08% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -106,479 | -100.0% | -2.16% | – |
| SHPG | Exit | SHIRE PLCsponsored adr | $0 | – | -37,391 | -100.0% | -2.20% | – |
| AMGN | Exit | AMGEN INC | $0 | – | -43,460 | -100.0% | -2.20% | – |
| NVS | Exit | NOVARTIS A Gsponsored adr | $0 | – | -92,125 | -100.0% | -2.21% | – |
| LLY | Exit | LILLY ELI & CO | $0 | – | -93,375 | -100.0% | -2.28% | – |
| BCR | Exit | BARD C R INCput | $0 | – | -35,000 | -100.0% | -2.38% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -66,375 | -100.0% | -2.47% | – |
| ABT | Exit | ABBOTT LABS | $0 | – | -205,000 | -100.0% | -2.63% | – |
| SYK | Exit | STRYKER CORPcall | $0 | – | -75,000 | -100.0% | -2.65% | – |
| SYK | Exit | STRYKER CORP | $0 | – | -84,333 | -100.0% | -2.98% | – |
| HCA | Exit | HCA HOLDINGS INCput | $0 | – | -140,000 | -100.0% | -3.22% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ICU MED INC | 26 | Q2 2023 | 4.2% |
| NANOSTRING TECHNOLOGIES INC | 26 | Q2 2023 | 3.3% |
| VIEWRAY INC | 25 | Q2 2023 | 3.2% |
| LIVANOVA PLC | 23 | Q3 2023 | 3.8% |
| ALEXION PHARMACEUTICALS INC | 23 | Q1 2021 | 4.3% |
| INSPIRE MED SYS INC | 22 | Q3 2023 | 3.7% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2022 | 4.8% |
| INVACARE CORP | 22 | Q3 2021 | 2.8% |
| ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 5.0% |
| INTERSECT ENT INC | 21 | Q2 2021 | 2.6% |
View PURA VIDA INVESTMENTS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stryve Foods Holdings, LLC | April 19, 2023 | 1,470,649 | 5.6% |
| ICAD INC | March 15, 2023 | 1,277,214 | 5.0% |
| ESTABLISHMENT LABS HOLDINGS INC. | February 14, 2023 | 1,002,767 | 4.1% |
| Pulmonx Corp | February 14, 2023 | 1,216,258 | 3.2% |
| Quotient LtdSold out | February 14, 2023 | 0 | 0.0% |
| Universe Pharmaceuticals INCSold out | February 14, 2023 | 0 | 0.0% |
| MedMen Enterprises, Inc. | April 29, 2022 | 139,755,072 | 21.4% |
| INVACARE CORPSold out | February 14, 2022 | 0 | 0.0% |
| MedAvail Holdings, Inc. | February 14, 2022 | 714,120 | 2.2% |
| TELA Bio, Inc. | February 14, 2022 | 564,120 | 3.9% |
View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2024-02-13 |
View PURA VIDA INVESTMENTS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.